wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38737493-08AAE049-642B-44CB-904D-BD2D048D5B4B
Q38737493-08AAE049-642B-44CB-904D-BD2D048D5B4B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38737493-08AAE049-642B-44CB-904D-BD2D048D5B4B
Bevacizumab for Metastatic Colorectal Cancer: A Global Cost-Effectiveness Analysis.
P2860
Q38737493-08AAE049-642B-44CB-904D-BD2D048D5B4B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38737493-08AAE049-642B-44CB-904D-BD2D048D5B4B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e1e846a0bfb4b63ef3404d097107b8d5d1402924
P2860
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).